QCM
URGN icon

Quantinno Capital Management’s UroGen Pharma URGN Stock Holding History

Quantinno Capital Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Sell
18,252
-1,924
-10% -$52.1K ﹤0.01% 2823
2026
Q1 		$363K Sell
20,176
-3,338
-14% -$66.9K ﹤0.01% 2930
2025
Q4 		$551K Buy
23,514
+3,205
+16% +$69.5K ﹤0.01% 2331
2025
Q3 		$405K Sell
20,309
-764
-4% -$13.7K ﹤0.01% 2202
2025
Q2 		$289K Buy
+21,073
New +$202K ﹤0.01% 2051

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Quantinno Capital Management's URGN Position: Q2 2026 in Review

Quantinno Capital Management reduced its UroGen Pharma (URGN) stake by 9.5% in Q2 2026, selling an estimated $52.1K and leaving 18,252 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #2823.

Quantinno Capital Management first reported a position in URGN in Q2 2025 and has held it in 5 quarters since. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Quantinno Capital Management held 18,252 shares of UroGen Pharma worth $672K as of Q2 2026.
  • Quantinno Capital Management sold 1,924 UroGen Pharma shares in Q2 2026, an estimated $52.1K.
  • UroGen Pharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2823 holding.
  • Quantinno Capital Management first reported a position in UroGen Pharma in Q2 2025 and has held it in 5 quarters since.
  • 190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.